|  | IL-10 | Cathepsin B | ||
---|---|---|---|---|---|
Variables | N | Median(Range) | p * value | Median (Range) | p * value |
age | Â | Â | Â | Â | Â |
   <58 | 26 | 31.3(3.05-530.3) | 0.252 | 10.9(0.9-51.9) | 0.41 |
   ≥58 | 37 | 30.5(0.6-511.6) |  | 14.5(0.6-69.1) |  |
Gender | Â | Â | Â | Â | Â |
   Male | 40 | 31.3(1.3-530.3) | 0.607 | 14.9(0.9-69.1) | 0.061 |
   Female | 23 | 19.9(0.6-426.1) |  | 10.1(0.6-37.9) |  |
Smoking history | Â | Â | Â | Â | Â |
   Never | 29 | 30.5(0.6-426.1) | 0.699 | 10.1(0.6-51.9) | 0.067 |
   Former or current | 34 | 31.2(1.3-530.3) |  | 14.9(1.5-69.1) |  |
Histology | Â | Â | Â | Â | Â |
   Adenocarcinoma | 34 | 42.9(0.6-530.3) | 0.045 | 12.7(0.6-69.1) | 0.41 |
   Squamous cell carcinoma | 20 | 17.1(1.3-354.3) |  | 16.6(1.5-41.7) |  |
   Others | 9 | 41.2(6.4-511.6) |  | 10.2(4.2-26.7) |  |
Pathological stage | Â | Â | Â | Â | Â |
   Stage I | 30 | 9.7(0.6-140.8) | 0.016 | 13.1(0.6-69.1) | 0.066 |
   StageII | 11 | 28.9(1.8-511.6) |  | 13.6(3.1-41.7) |  |
   StageIII | 17 | 177.7(23.5-530.3) |  | 11.8(1.2-51.9) |  |
   StageIV | 5 | 249.9(55.4-429.9) |  | 10.1(3.6-25.9) |  |
T status | Â | Â | Â | Â | Â |
   T1 | 15 | 4.1(0.6-263.6) | <0.0001 | 9.9(0.6-22.7) | 0.037 |
   T2-3 | 48 | 42.9(1.6-530.3) |  | 14.2(0.9-69.1) |  |
Lymph node metastasis | Â | Â | Â | Â | Â |
   N(+) | 21 | 119.1(6.1-530.3) | <0.0001 | 13.6(1.2-46.9) | 0.466 |
   N(-) | 42 | 19.2(0.6-273.8) |  | 11.1(0.6-69.1) |  |
Lymphovascular invasion | Â | Â | Â | Â | Â |
   LVI(+) | 12 | 93.1(6.2-530.3) | 0.01 | 14.2(0.9-37.8) | 0.92 |
   LVI(-) | 51 | 26.5(0.6-429.9) |  | 11.1(0.6-69.1) |  |
Pleural invasion | Â | Â | Â | Â | Â |
   PL(+) | 20 | 55.8(14.9-530.3) | 0.002 | 14.2(0.9-69.1) | 0.376 |
   PL(-) | 43 | 19.9(0.6-354.9) |  | 11.1(0.6-51.9) |  |
Differentiation | Â | Â | Â | Â | Â |
   Well or Moderately | 30 | 17.3(0.6-429.9) | 0.001 | 13.0(0.6-69.1) | 0.961 |
   poorly | 26 | 113.1(1.6-530.3) |  | 11.9(1.2-37.9) |  |